Telehealth Psychiatric Nurse Practitioner, Licensed

This is a fully remote position, open to applicants in Connecticut.

📋 Description

• Perform patient intake and follow-up consultations to assess eligibility for ketamine-assisted psychotherapy (KAP), prescribe treatments, and monitor patient outcomes through telemedicine.

• Recommend modifications to treatment plans based on patient responses to medication and overall treatment results.

• Collaborate with Journey Clinical psychotherapists as part of a cohesive care team.

• Partner with the Journey Clinical care coordinator to optimize your workflow.

• Provide timely and constructive feedback on the Journey Clinical care management system to enhance our services.

• Directly report to the Lead Clinician and work closely with the leadership team and co-founders.

⛳️ Requirements

• Must be licensed to practice in Connecticut.

• Preferred: At least 1 year of psychiatric experience as a PMHNP.

• Minimum of 1 year of psychiatric-related experience plus post-boards.

• DEA registration is required.

• Must be comfortable prescribing controlled substances when clinically appropriate.

• Should be able to prescribe for anxiety and depression.

• Ability to quickly integrate medical and psychiatric information to develop effective, evidence-based clinical recommendations.

• A patient-first mindset with a strong work ethic and commitment to delivering the highest level of patient care.

• Willingness to utilize basic tools to enhance your work efficiency (e.g., Slack, G Suite, Zoom, etc.).

• Comfortable operating in a remote, fast-paced telehealth startup environment.

• A keen interest in psychedelic-assisted psychotherapy to revolutionize mental health care.

🏝️ Benefits

• Competitive hourly compensation.

• Flexible working hours.

• Training and mentorship in ketamine-assisted psychotherapy (KAP) provided by leading industry experts.

• Collaborate with a team of industry-leading experts who are highly cooperative, disciplined, and enjoy working together.

• Opportunity to transform mental health care by promoting the mainstream acceptance of psychedelic-assisted psychotherapy, positively impacting the lives of over 100 million individuals suffering from depression and anxiety in the US today!